N=1协作:通过合作和数据共享来推进定制核酸疗法
Jillian Belgrad1,2, Erin McConnell2,3, Stef Leonard2
1RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
Nucleic acids research
|April 25, 2025
概括
N=1协作 (N1C) 正在为个性化药物建立一个开放的生态系统,最初将重点放在罕见神经退行性疾病的抗意义寡核酸 (ASO) 上,以实现安全,可扩展的基因向疗法.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学是一种遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 超罕见疾病影响全球数百万人,需要创新的治疗和监管方法.
- 个性化医学的进步正在推动核酸治疗的进步,包括剂量,安全性和有效性.
- N=1协作 (N1C) 成立的目的是团结利益相关者,为个性化药物创建一个共享的生态系统.
研究的目的:
- 审查目前的科学和临床生态系统,以定制基因疗法.
- 探索提供个性化药物的必要创新,框架和系统.
- 检查反感性寡核酸 (ASO) 开发的进展和未来方向.
主要方法:
- 召集科学,监管和宣传领域的领导人参加2024年10月关于ASO发展的首次会议.
- 检查了个性化医疗发展的现有格局.
- 综合了关于使基因向疗法的安全和可扩展的交付的见解.
主要成果:
- N1C最初专注于用于罕见,致命的神经退行性疾病的反感性寡核酸 (ASO).
- 该协作旨在将其框架扩展到其他治疗方式和疾病.
- 个性化疗法的进展为核酸治疗提供了关键的见解.
结论:
- 开发定制的基因向疗法需要显著的治疗和监管创新.
- 开放,共享的生态系统对于推进个性化药物的发展至关重要.
- 需要框架来安全地和规模地提供个性化药物.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
DNA Microarrays
17.0K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
17.0K
Next-generation Sequencing
86.1K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.1K


